Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis.
George Athanasios KarpouzasSarah R OrmsethPiet Leonardus Cornelis Maria van RielMiguel Angel González-GayAlfonso CorralesSolbritt Rantapää DahlqvistPetros P SfikakisPatrick DesseinLinda TsangCarol HitchonHani El-GabalawyVirginia Pascual-RamosIrazú Contreras-YáñezIris Jazmin Colunga-PedrazaDionicio Ángel Galarza-DelgadoJose Ramon Azpiri-LopezAnne Grete SembDurga Prasanna MisraEllen-Margrethe HaugeGeorge KitasPublished in: RMD open (2024)
RA activity and inflammatory markers associated with risk of MACE in bDMARD non-users but not users suggesting the possibility of biological-specific benefits locally on arterial wall independently of effects on systemic inflammation.